Onderneming Oncolytics Biotech Inc. Nasdaq
Aandelen
CA6823101077
Biotechnologie & Medisch Onderzoek
Vakgebied
Managers
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Matthew Coffey
CEO | Chief Executive Officer | - | 11-05-11 |
Kirk Look
DFI | Director of Finance/CFO | - | 01-04-03 |
Thomas Heineman
CTO | Chief Tech/Sci/R&D Officer | - | 01-08-20 |
Jon Patton
IRC | Investor Relations Contact | - | 01-08-20 |
Besturend
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Jonathan Rigby
BRD | Director/Board Member | 56 | 07-09-22 |
Patricia Andrews
BRD | Director/Board Member | 66 | 09/01 |
Bernd Seizinger
BRD | Director/Board Member | 67 | 08-06-15 |
James Parsons
BRD | Director/Board Member | 58 | 16-06-22 |
Angela Holtham
BRD | Director/Board Member | 73 | 18-06-14 |
Matthew Coffey
CEO | Chief Executive Officer | - | 11-05-11 |
Wayne Pisano
CHM | Chairman | 69 | 09-05-13 |
Deborah Brown
BRD | Director/Board Member | - | 02-11-17 |
Aandelenklasse
Stemming | Aantal | Vrij verhandelbaar | Bedrijfseigen aandelen | Drijvend Totaal | |
---|---|---|---|---|---|
Aandeel A | 1 | 75 419 768 | 72 478 872 ( 96,10 %) | 0 | 96,10 % |
Bedrijfsgegevens
Oncolytics Biotech, Inc.
322–11th Avenue SW Suite 804
T2R 0C5, Calgary
+
http://www.oncolyticsbiotech.comSector
Vaira. 1 jan. | Kapi. | |
---|---|---|
+29,26% | 49,46 mld. | |
+0,54% | 42,58 mld. | |
+48,94% | 42,49 mld. | |
-5,26% | 29,09 mld. | |
+12,24% | 26,61 mld. | |
-24,12% | 18,64 mld. | |
+7,57% | 13,16 mld. | |
+31,96% | 12,55 mld. | |
+24,12% | 12,1 mld. |